Evidence map›Paper›PMID 31098742›Full record

ArticleJournal of ophthalmic inflammation and infection2019

Infectious endophthalmitis leading to evisceration: spectrum of bacterial and fungal pathogens and antibacterial susceptibility profile.

Tarjani Vivek Dave, Vivek Pravin Dave, Savitri Sharma, Roshni Karolia, Joveeta Joseph, Avinash Pathengay, Rajeev R Pappuru, Taraprasad Das

Open access · goldAbstract read
In one paragraph

Article in Journal of ophthalmic inflammation and infection, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Journal of fungi (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Review
  15. Endophthalmitis Caused byJournal of ophthalmology · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Treatment-Resistant Bacterial Keratitis: Challenges and Solutions.Clinical ophthalmology (Auckland, N.Z.) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tarjani Vivek DaveOphthalmic Plastic Surgery Service, KallamAnji Reddy Campus, LV Prasad Eye Institute, Hyderabad, Telangana, India.
Vivek Pravin DaveSmt. Kanuri Santhamma Center for Vitreoretinal Diseases, KallamAnji Reddy Campus, LV Prasad Eye Institute, Hyderabad, Telangana, 500034, India. vivekoperates@yahoo.co.in.
Savitri SharmaJhaveri Microbiology Center, Brien Holden Eye Research Center, LV Prasad Eye Institute, Hyderabad, India.
Roshni KaroliaJhaveri Microbiology Center, Brien Holden Eye Research Center, LV Prasad Eye Institute, Hyderabad, India.
Joveeta JosephJhaveri Microbiology Center, Brien Holden Eye Research Center, LV Prasad Eye Institute, Hyderabad, India.
Avinash PathengayRetina and Uveitis Department, GMR Varalaxmi Campus, LV Prasad Eye Institute, HanumanthawakaChowk, Visakhapatnam, Andhra Pradesh, 530040, India.
Rajeev R PappuruSmt. Kanuri Santhamma Center for Vitreoretinal Diseases, KallamAnji Reddy Campus, LV Prasad Eye Institute, Hyderabad, Telangana, 500034, India.
Taraprasad DasSmt. Kanuri Santhamma Center for Vitreoretinal Diseases, KallamAnji Reddy Campus, LV Prasad Eye Institute, Hyderabad, Telangana, 500034, India.
L V Prasad Eye Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe the spectrum of bacterial and fungal pathogens in cases of endophthalmitis requiring evisceration and report their antimicrobial susceptibilities.

methodsRetrospective, consecutive, and descriptive case series of endophthalmitis that underwent evisceration from January 2004 to December 2017. Vitreous samples from all patients had been investigated for bacteria and fungus using institutional protocol. Bacterial isolates were identified using analytical profile index (API) system until 2010 and Vitek-2 compact system (bioMérieux, France), thereafter. The susceptibility of bacterial isolates to a variety of antibiotics was determined by the Kirby-Bauer disk-diffusion method.

resultsOf 791 cases reviewed, culture positivity was reported in 388 cases (48.92%). Commonest clinical setting of endophthalmitis necessitating evisceration was post-microbial keratitis (58%), followed by post-trauma and post-cataract surgery (14-15%). The commonest isolate was Streptococcus pneumoniae, seen in 68 samples overall (17.52%). One hundred and eighty-three isolates (47.16%) were gram-positive, 86 (22.16%) were gram-negative, and fungi constituted 137 (35.3%) isolates. Streptococcus pneumoniae was the commonest gram-positive bacterial isolate seen in 68/183 samples (37.15%). Among gram-negative organisms, the commonest was Pseudomonas aeruginosa seen in 47/86 (54.65%). Aspergillus spp. formed the commonest fungal isolate, 58/137 (42.33%). The susceptibility of the gram-positive bacteria was highest with vancomycin, 136/147 (92.51%) and for gram-negative bacteria was seen best with imipenem 24/29 (82.75%). Susceptibility to ceftazidime was 31/61 (50.81%) in 31/61.

conclusionEndophthalmitis due to Pneumococci, Aspergillus, and Pseudomonas can be very fulminant and progress to require evisceration in spite of prompt and appropriate treatment.

Indexed as

EndophthalmitisEviscerationMicrobiologic profile

Identifiers

PMID31098742
PMCPMC6522574
OpenAlexW2947860419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.